U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839131) titled 'A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.' on Feb. 18.
Brief Summary: The purpose of the study is to evaluate the safety of SPH9788 tablets in healthy subjects.
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: SPH9788
SPH9788 tablets administered orally
DRUG: Placebo
Matching placebo administered orally
Recruitment Status: RECRUITING
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Published by HT Digital Content Services with permission from Health Daily Digest....